Skip to main content
logo
Viva Biotech Holdings (HKG:1873)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.530
+0.105 (7.37%)
Sep 30, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Drug Discovery Services
854.72M821.31M866.76M895.06M740.47M
Elimination
-28.69M-32.09M-56.54M--
Contract Development Manufacture Organisation (CDMO) and Commercialisation Services
894.11M1.18B1.31B1.48B1.36B
Viva Bioinnovator
9.31M18.09M30.61M--
Total
1.73B1.99B2.16B2.38B2.10B

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States of America (USA)
830.80M795.83M812.79M915.82M646.52M
Europe
461.28M623.34M589.56M508.47M590.23M
Chinese Mainland
259.65M267.23M323.67M382.38M376.74M
Other Asia countries and regions out of Chinese Mainland
92.27M193.53M291.39M392.80M330.08M
Africa
17.82M45.27M45.03M64.55M74.18M
Others
67.63M61.47M93.14M115.62M86.34M
Total
1.73B1.99B2.16B2.38B2.10B